| Literature DB >> 32405417 |
Yukiko Hibino1, Ryosuke Imai2, Torahiko Jinta2.
Abstract
Diffuse large B-cell lymphoma (DLBCL) with cavitary lung disease is rare and is often difficult to differentiate from primary lung cancer, granulomatous disease, or an infectious disease based on imaging findings alone. We herein report a case in which a patient with DLBCL presented with cavitary lung disease and splenic mass, which was diagnosed by transbronchial biopsy. DLBCL should be considered as a differential diagnosis in patients with cavitary lung diseases who have rare metastatic lesions for primary lung cancer, such as intra-abdominal lymph nodes or spleen.Entities:
Keywords: Cavitary lung disease; diffuse large B‐cell lymphoma
Year: 2020 PMID: 32405417 PMCID: PMC7214784 DOI: 10.1002/rcr2.584
Source DB: PubMed Journal: Respirol Case Rep ISSN: 2051-3380
Figure 1Computed tomography (CT) axial images. (A) A large mass with a cavity on the right hilar area (8.4 × 6.3 cm in size). (B, C) A splenic mass (9.0 × 8.3 cm in size) with low‐density area indicating necrotic lesion.
Clinical features of DLBCL cases with pulmonary cavitation.
| Miyahara (2001) [ | Yamane (2011) [ | Matsumoto (2015) [ | Insiripong (2018) [ | |
|---|---|---|---|---|
| Age | 27 | 68 | 80 | 80 |
| Sex | Male | Female | Male | Male |
| C.C. | Cough | Cough, haemoptysis | Fever | Dyspnoea |
| Extrapulmonary lesions | N/A | Stomach | Spleen | N/A |
| Initial diagnosis after bronchoscopy | GPA | Non‐diagnostic | Lung abscess | Lung abscess |
| Treatment | CHOP | R‐CHOP | Prednisolone and antibiotics | R‐CHOP |
C.C., chief complaint; CHOP, cyclophosphamide, doxorubicin, vincristine, prednisolone; DLBCL, diffuse large B‐cell lymphoma; GPA, granulomatosis with polyangiitis; N/A, not applicable; R‐CHOP, rituximab, cyclophosphamide, doxorubicin, vincristine, prednisolone.